CELZ

Conviction 31FinancialsScan · Thu, Jun 25, 2026

CELZ$2.02+0.75%

ResistanceSupportVol 14

Vol MA14 80.23K

Mar 26Apr 14May 1May 19Jun 8Jun 25

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.creativemedicaltechnology.com ↗

Price2.02

Change+0.75%

Gap-1.00%

Rel volume2.56×

Avg volume77.26K

Avg $ vol166.31K

SMA 202.16

SMA 502.22

SMA 2002.47

Price vs 50-9.32%

Price vs 200-18.36%

MA stackbearish

50/200 cross—

Supertrenddown · 2.46

RSI (14)42

MACD hist-0.02

MACD crossbear · 3d

Stoch %K / %D17 / 13

ADX (14)16

+DI / −DI16 / 19

RSI divergence—

MACD divergenceBullish

ATR %+7.89%

ADR %7.24%

52w high5.59

52w low1.78

From 52w high-63.95%

Above 52w low+13.20%

New 52w highNo

SqueezeOff

Bollinger width20.87%

%B0.18

Donchian pos16.67%

Donchian high2.49

Donchian low1.92

AVWAP (52w high)2.49

vs AVWAP high-19.14%

AVWAP (52w low)2.11

vs AVWAP low-4.63%

OBV trendDown

Chaikin MF (20)-0.28

Today vs 20d2.56×

Avg vol (14d)80.23K

Avg vol (20d)77.26K

Avg $ vol (20d)166.31K

Market cap7.45M

RS 3m (vs SPY)-1.76%

RS 6m (vs SPY)-12.95%

RS line new highNo

Trend template0/8

Technical rank23.7

1 week-10.04%

1 month-13.89%

3 months+7.75%

6 months-4.95%

1 year-22.50%

YTD+2.28%

P/E-1.24

P/B1.22

P/S—

P/FCF—

EPS-2.52

Div yield—

ROE-98.12%

ROA-93.08%

Debt/Eq0.84

Current19.69

EV/EBITDA-1.33

Gross margin63.43%

Net margin—

Rev growth-45.45%

EPS growth-9.13%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value8.09M

Revenue0

Net income-1.41M

Gross profit0

Free cash flow—

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out3.7M

Employees4

ListedThu, Apr 30, 2009

Free float3.66M

Float %99.1%

Short interest135.63K

Days to cover2.8d

Short volume20.7%

Squeeze score36 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction31 / 100

Pattern quality—

Tech rank23.7 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.45

Support1.96

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CELZ

All disclosures →

No recent disclosed trades by Congress in CELZ. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CELZ

No recent insider (Form 4) filings in CELZ. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in CELZ · 1 recent

EDGAR →

OFFERS-1Thu, Jun 25, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.